DU
BLUE

Delphia (USA)’s bluebird bio BLUE Stock Holding History

Delphia (USA)’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-955
Closed -$191K – 332
2021
Q4 		$191K Buy
+955
New +$225K 0.2% 226

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Delphia (USA)'s BLUE Position: Q1 2022 in Review

Delphia (USA) sold out of bluebird bio (BLUE) in Q1 2022, closing a stake of 955 shares — an estimated $191K sold.

Delphia (USA) first reported a position in BLUE in Q4 2021 and held it in 1 quarter. The position peaked at $191K in Q4 2021. 174 funds tracked by Wall St. Rank hold BLUE as of Q1 2022.

  • Delphia (USA) reported no remaining bluebird bio position as of Q1 2022 after selling out during the quarter.
  • Delphia (USA) sold 955 bluebird bio shares in Q1 2022, an estimated $191K.
  • Delphia (USA) first reported a position in bluebird bio in Q4 2021 and held it in 1 quarter.
  • Delphia (USA)'s bluebird bio position peaked at $191K in Q4 2021.
  • 174 funds tracked by Wall St. Rank held bluebird bio as of Q1 2022.

Based on Delphia (USA)'s 13F filing for Q1 2022, filed 16 May 2022.